Re: real world clinical outcome of cefiderocol for treatment of multidrug-resistant non-fermenting gram-negative bacilli infections: author's response

Affiliations

¹ Department of Infectious and Tropical Diseases, Hôpitaux Universitaires de Strasbourg, Strasbourg, France. Electronic address: baptiste.hoellinger@chru-strasbourg.fr.
² Department of Infectious and Tropical Diseases, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
³ Department of Bacteriology, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Free article

Comment

Baptiste Hoellinger et al. Clin Microbiol Infect. 2023 Jun.

Free article

. 2023 Jun;29(6):812-813.

doi: 10.1016/j.cmi.2023.02.019. Epub 2023 Mar 5.

¹ Department of Infectious and Tropical Diseases, Hôpitaux Universitaires de Strasbourg, Strasbourg, France. Electronic address: baptiste.hoellinger@chru-strasbourg.fr.
² Department of Infectious and Tropical Diseases, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
³ Department of Bacteriology, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

No abstract available

Comment on

Real-world clinical outcome of cefiderocol for treatment of multidrug-resistant non-fermenting, gram negative bacilli infections: a case series.
Hoellinger B, Simand C, Jeannot K, Garijo C, Cristinar M, Reisz F, Danion F, Ursenbach A, Lefebvre N, Boyer P, Hansmann Y, Studer A, Schramm F, Ruch Y. Hoellinger B, et al. Clin Microbiol Infect. 2023 Mar;29(3):393-395. doi: 10.1016/j.cmi.2022.11.005. Epub 2022 Nov 18. Clin Microbiol Infect. 2023. PMID: 36410645 No abstract available.
Re: 'Real world clinical outcome of cefiderocol for treatment of multidrug-resistant nonfermenting gram-negative bacilli infections' by Hoellinger et al.
Larcher R, Laffont-Lozes P, Loubet P, Laureillard D, Naciri T, Sotto A. Larcher R, et al. Clin Microbiol Infect. 2023 Jun;29(6):808-811. doi: 10.1016/j.cmi.2023.01.022. Epub 2023 Feb 3. Clin Microbiol Infect. 2023. PMID: 36739087 No abstract available.